Pharmaceutical Supply for Indian Army Medical Needs

Work Description - NA

This tender, identified by Bid Number GEM/2026/B/7606500, is being issued by the Department of Military Affairs, Ministry of Defence, on behalf of the Indian Army, with an office located in Kolkata. The bid is open from July 9, 2026, at 11:19 AM, and will close on August 6, 2026, at 12:00 PM. The tender seeks the supply of a comprehensive range of pharmaceutical products, totaling 3759 units, which includes critical medications such as Remogliflozin 100 mg tablets, Inj Romosozumab 210 mg, Insulin Lispro IpointP IU 3 ml solution for injection in a pre-filled pen (half 0.5 unit dose dialing), Inj Arachitol 6 lac IU, Inj VitpointD3 600000 IU, various formulations of Semaglutide injections (0.25 mg, 0.50 mg, 1.0 mg, 1.7 mg, 2.4 mg in pre-filled pens), Vitamin D3 Oral Solution NANO 60K IU in 5ml bottles, Inj Triptorelin Palmoate 11.25 mg, Tab Ezetimibe 10 mg, and Inj Somatotropin Recombinant Growth Hormone 4 IU per ml (each in a vial with insulin syringe and distilled water). This procurement is essential for supporting the medical needs of personnel under the purview of the Indian Army.